Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer

Clinical trial NCT04720729 · TERMINATED

Trial details

NCT number: NCT04720729
Sponsor: Institut Curie
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-negative Metastatic Breast Cancer

Start date: 2021-04-21
Primary completion: 2025-04-21
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.